A population can be identified, and riskcan be determined by correlating the SNP allele with the severity of disease in terms of clinicohistophathological variables [e.g. age, Gleason score (GS)]. Finally, each SNP is given a number and a statistical value representing the Population Attributable Risk (PAR). The result of this work is that one specific change in DNA sequence can be examined in tho